INVESTORS & MEDIA
News Release
Regeneron Announces Change in Date for Presentation at Barclays Capital 2012 Global Healthcare Conference
The session may be accessed through the Company's web site, www.regeneron.com, on the Events and Presentations page. An archived version of the presentation will be available for thirty days after the live webcast.
Regeneron is a fully integrated biopharmaceutical company that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions. Regeneron markets two products in
Contact Information: |
|
|
|
|
|
Investor Relations |
Corporate Communications |
914-847-5126 |
914-847-7640 |
SOURCE
News Provided by Acquire Media